RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,046,178 | -48.6% | 119,700 | -53.0% | 0.01% | -48.1% |
| Q4 2022 | $2,037,024 | +248.8% | 254,628 | +112.7% | 0.03% | +237.5% |
| Q3 2022 | $584,000 | -12.3% | 119,700 | 0.0% | 0.01% | -20.0% |
| Q2 2022 | $666,000 | +9.7% | 119,700 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $607,000 | -60.6% | 119,700 | 0.0% | 0.01% | -54.5% |
| Q4 2021 | $1,542,000 | -13.9% | 119,700 | 0.0% | 0.02% | -24.1% |
| Q3 2021 | $1,791,000 | -3.7% | 119,700 | 0.0% | 0.03% | -17.1% |
| Q2 2021 | $1,860,000 | – | 119,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |